Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
We also supply nucleic acid lateral flow immunoassays and antibodies. Learn more: www.abingdonhealth.com/other-products
Seralite® – FLC Serum
Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.Read More
Lateral flow assay reagents
A key element of any lateral flow assay development project is the […]Read More
See how Abingdon Health can aid the development of a near-patient testing solution to help your therapeutic or bios… https://t.co/rIa9ksK1SP
16 September 2019
© Abingdon Health 2019